Stock Analysis: Abbott Laboratories (ABT)

Stock Analysis for Abbott Laboratories (ABT)

The Interpreter
Hey Friend, I'm analysing ABBOTT LABORATORIES (ABT), and it is between the Support of $ 105.50 (100% of Fibonacci) and the Resistance of $ 106.38 (Pivot).

Abbott Laboratories (ABT)

$ 105.63 -0.3%

Last Close 06-May-24

Trade ABT Now

Supports

Next Support: $ 105.50

Pivot S1: $ 104.67
Fibonacci 100%: $ 105.50
Triangle Level (0): $ 104.96

Resistances

Next Resistance: $ 106.38

Pivot: $ 106.38
Fibonacci 138.2%: $ 109.60
Triangle Level (0): $ 116.76

Supports and Resistances

Click to Enlarge

Candlesticks, "48-hour" Trade Signals +

Date	Price $	Result %	Candle Name	Side
001 02 May 2024	Sell Price: 105.92	Profit: Close Day1 ($ 105.90)	Engulfing	Sell
002 02 May 2024	Sell Price: 105.95	Profit: Close Day1 ($ 105.90)	Dark Cloud Cover	Sell
003 24 Apr 2024	Sell Price: 106.89	Profit: Open Day1 ($ 106.65)	Abandoned Baby	Sell
004 26 Mar 2024	Buy Price: 111.50	Profit: Open Day1 ($ 112.00)	Abandoned Baby	Buy
005 29 Feb 2024	Sell Price: 118.64	Profit: Open Day1 ($ 118.57)	Engulfing	Sell
006 27 Feb 2024	Buy Price: 119.40	Profit: Open Day1 ($ 119.49)	Piercing Line	Buy
007 26 Feb 2024	Sell Price: 118.69	Profit: Open Day1 ($ 118.16)	Engulfing	Sell
008 12 Feb 2024	Buy Price: 112.53	Loss: Close Day2 ($ 112.02)	Engulfing	Buy
009 20 Dec 2023	Sell Price: 107.40	Loss: Close Day2 ($ 109.03)	Abandoned Baby	Sell
010 26 Oct 2023	Buy Price: 93.98	Profit: Open Day1 ($ 94.75)	Piercing Line	Buy
011 04 Oct 2023	Sell Price: 95.05	Loss: Close Day2 ($ 96.86)	Engulfing	Sell
012 04 Oct 2023	Sell Price: 95.65	Loss: Close Day2 ($ 96.86)	Dark Cloud Cover	Sell
013 03 Oct 2023	Buy Price: 95.69	Profit: Open Day1 ($ 95.89)	Abandoned Baby	Buy
014 03 Oct 2023	Buy Price: 95.79	Profit: Open Day1 ($ 95.89)	Engulfing	Buy
015 15 Aug 2023	Sell Price: 104.94	Profit: Open Day1 ($ 104.46)	Engulfing	Sell
016 08 Aug 2023	Sell Price: 105.58	Profit: Open Day1 ($ 105.50)	Abandoned Baby	Sell
017 04 Aug 2023	Buy Price: 107.65	Profit: Open Day1 ($ 107.99)	Piercing Line	Buy
018 19 Jul 2023	Buy Price: 107.28	Profit: Open Day1 ($ 108.10)	Abandoned Baby	Buy
019 27 Jun 2023	Sell Price: 107.79	Profit: Close Day1 ($ 107.61)	Engulfing	Sell
020One Year Average	Both Sides Result for 19 Signals	Loss: $ -0.69 ($ -0.04 / Signal) -0.6% Gross in 1 Year	All of Them	Buy + Sell

Trading Rules for Candlesticks Patterns.

Buy or Sell on the same day of the signal, during the after-hours trading session.
Watch the Opening and Closing of the next 2 days (4 in total).
Immediately exit the Trade when one of them (Open or Close, Day 1 or 2) gives you a profit.
The table above will show the first Profit opportunity, but not in real-time. Therefore, you must watch the market in real-time with your broker.

Remember: The returns an asset made in the past don't mean that future returns will be the same.

Backtest Lab, "Buy The Dip" Trade Signals +

Find The Lastest Buy Signals for ABT Below.

Please Subscribe to See
The Latest Trade Signals

Moving Averages +

Bought Moving Averages

Sold Moving Averages

Simple Moving Averages (SMA) Period	Value $	Signal	Exponential Moving Averages (EMA) Period	Value $	Signal
2	105.86	BUY	2	105.97	BUY
3	105.87	BUY	3	105.96	BUY
5	105.97	BUY	5	106.05	BUY
8	106.33	SELL	8	106.28	SELL
13	106.64	SELL	13	106.76	SELL
21	107.61	SELL	21	107.69	SELL
34	109.09	SELL	34	109.02	SELL
55	112.70	SELL	55	110.10	SELL
90	112.67	SELL	90	110.12	SELL
200	106.59	SELL	200	108.53	SELL

Company Info +

Name & IPO

Abbott Laboratories
IPO: 1937-03-01

Stock Ticker & Exchange

Ticker: ABTIndices: S&P 500,
Exchange: New York Stock Exchange, Inc. (US - USD)

Contact

Website: https://www.abbott.com/
Phone:

Stock Type

Common Stock

SIC Office

Life Sciences ()

Industry

Pharmaceutical Preparations

EIN

Fiscal Year End

State of Inc.

Balance Sheets +

in USD millions (if not decimal) - Dictionary

	Year	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
1	Assets +	72,548	67,887	67,173	76,250	52,666	41,247	41,275	42,953	67,235	60,277	59,462	52,417	42,419	39,714	521
2	Current Assets +	20,441	15,667	14,632	20,147	26,776	14,155	15,261	19,247	31,323	23,769	22,318	23,314	17,043	14,043	521
3	Cash +	7,148	4,140	4,086	9,610	18,775	6,125	4,460	8,098	15,174	8,098	7,626	11,065	6,153	2,820	521
4	Current Receivables +	6,414	5,425	5,182	5,249	3,248	3,418	3,586	3,986	7,613	7,684	7,184	6,542	5,466	4,947	0
5	Inventory +	5,012	4,316	3,796	3,601	2,434	2,599	2,643	2,693	3,792	3,284	3,189	3,265	2,776	2,951	0
6	Current Other Assets +	0	0	0	1,667	1,806	1,908	1,975	1,504	1,757	2,003	1,545	1,211	1,259	1,214	0
7	Current Disposal Group +	0	0	9	20	513	105	892	438	0	0	0	0	0	0	0
8	Total Current Assets +	20,441	15,667	14,632	20,147	26,776	14,155	15,261	19,247	31,323	23,769	22,318	23,314	17,043	14,043	0
9	Long-Term Other Undisclosed Assets	2,541	2,055	1,766	1,825	-607	-23	0	0	0	0	0	0	0	1	0
10	Long-Term Assets +	52,107	52,220	52,541	56,103	25,890	27,092	26,014	23,705	35,912	36,508	37,092	29,103	25,377	25,671	0
11	Operating Lease +	1,101	934	0	0	0	0	0	0	0	0	0	0	0	0	0
12	Property +	9,029	8,038	7,563	7,607	5,705	5,730	5,935	5,905	8,063	7,874	7,971	7,619	7,219	7,518	0
13	Long-term Investments and Receivables +	821	883	897	883	2,947	4,041	229	119	274	378	302	1,133	1,074	1,125	0
14	Goodwill +	23,744	23,195	23,254	24,020	7,683	9,638	10,067	9,772	15,774	15,705	15,930	13,200	9,987	10,129	0
15	Intangible Assets +	14,784	17,025	18,942	21,473	4,539	5,562	6,198	5,735	8,588	9,990	12,152	6,292	5,151	5,720	0
16	Long-Term Other Assets +	0	0	0	0	0	2,119	1,651	2,109	3,213	2,561	790	858	1,945	1,178	0
17	Long-Term Regulated Entity +	87	90	102	119	117	21	0	0	0	0	0	0	0	0	0
18	Long-Term Disposal Group +	0	0	17	176	5,506	4	2,738	66	0	0	0	0	0	0	0
19	Total Long-Term Assets +	0	0	0	0	0	0	26,014	23,705	35,912	36,508	37,092	29,103	25,377	0	0
20	Total Assets +	72,548	67,887	67,173	76,250	52,666	41,247	41,275	42,953	67,235	60,277	59,462	52,417	42,419	39,714	0
21	Liabilities and Equity +	72,548	67,887	67,173	76,250	52,666	41,247	41,275	42,953	67,235	60,277	59,462	52,417	42,419	39,714	14,054
22	Liabilities +	11,907	10,863	9,012	8,912	6,660	9,186	10,532	9,507	13,280	15,480	17,262	13,049	11,592	9,103	0
23	Current Liabilities +	11,907	10,863	9,012	8,912	6,660	9,186	10,532	9,507	13,280	15,480	17,262	13,049	11,592	9,103	0
24	Long-Term Liabilities +	19,429	17,416	21,399	36,240	25,419	10,883	9,104	8,179	27,141	20,271	19,724	16,468	13,308	12,787	0
25	Stockholders' Equity +	33,003	31,301	30,722	31,098	20,717	21,326	21,639	25,267	26,813	24,526	22,476	22,899	17,519	17,824	14,054
26	Stockholders' Equity Attributable to Parent +	32,784	31,088	30,524	30,897	20,538	21,211	21,526	25,171	26,721	24,440	22,388	22,856	17,480	17,779	0
27	Stockholders' Equity Attributable to Noncontrolling Interest +	219	213	198	201	179	115	113	96	92	86	88	43	39	45	0
28	Total Stockholders' Equity +	33,003	31,301	30,722	31,098	20,717	21,326	21,639	25,267	26,813	24,526	22,476	22,899	17,519	17,824	14,054
29	Stockholders' Equity +	1	1	1	1	1	1	1	1	11,756	9,818	8,746	8,259	1	1	0
30	Preferred Stock +	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0
31	Common Stock +	0	0	0	0	0	0	0	0	11,755	9,817	8,745	8,258	0	0	0
32	Partners' Capital +	27,627	25,847	24,560	23,978	25,565	25,757	22,874	21,979	24,151	20,907	18,927	17,054	13,825	10,806	0
33	Partners' Capital +	27,627	25,847	24,560	23,978	25,565	25,757	22,874	21,979	24,151	20,907	18,927	17,054	13,825	10,806	0
34	Limited Liability Company (LLC) Members' Equity +	18,681	17,382	16,974	17,916	18,302	19,099	17,821	19,967	20,557	18,310	17,560	17,908	12,661	12,888	0
35	Limited Liability Company (LLC) Members' Equity +	18,681	17,382	16,974	17,916	18,302	19,099	17,821	19,967	20,557	18,310	17,560	17,908	12,661	12,888	0
36	Total Liabilities and Equity +	72,548	67,887	67,173	76,250	52,666	41,247	41,275	42,953	67,235	60,277	59,462	52,417	42,419	39,714	0

Income Statement +

in USD millions (if not decimal) - Dictionary

Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.